Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells

Cancer Gene Therapy, Published online: 09 June 2022; doi:10.1038/s41417-022-00486-xActivation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells

https://www.nature.com/articles/s41417-022-00486-x

Source: Cancer Gene Therapy - June 9, 2022 Category: Cancer & Oncology Authors: Ilan Zaffran Nadine Landolina Pratibha Gaur Tihana Lenac Rovis Jonjic Stipan Ofer Mandelboim Bernhard B. Singer Francesca Levi-Schaffer Source Type: research